Showing results (11-20 of 25) with videos related to
Sort By:
Pageof 3
The British Journal of Radiology|July 1, 1996
Clinical evaluation of manual and automatic exposure control techniques in film-based chest radiographyE Ismailos, I Mastorakou, N L Kelekis, et al.ESMO Open|July 23, 2024
Safety and clinical activity of durvalumab combined with tremelimumab in recurrent/metastatic head and neck squamous cell carcinoma: a multicenter phase I studyA Algazi, K P Papadopoulos, F Tsai, et al.Journal of Hematotherapy & Stem Cell Research|January 14, 2000
CD34+ cell dose requirements for rapid engraftment in a sequential high-dose chemotherapy regimen of paclitaxel, melphalan, and cyclophosphamide, thiotepa, and carboplatin (CTCb) with PBPC support in metastatic breast cancerK P Papadopoulos, J Ayello, R F Reiss, et al.Cancer Chemotherapy and Pharmacology|February 28, 2001
The pharmacokinetics and pharmacodynamics of high-dose paclitaxel monotherapy (825 mg/m2 continuous infusion over 24 h) with hematopoietic support in women with metastatic breast cancerK P Papadopoulos, M J Egorin, M Huang, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 10, 2015
A phase I, first in human study of FP-1039 (GSK3052230), a novel FGF ligand trap, in patients with advanced solid tumorsA W Tolcher, K P Papadopoulos, A Patnaik, et al.Journal of Hematotherapy|February 1, 1997
Harvest quality and factors affecting collection and engraftment of CD34+ cells in patients with breast cancer scheduled for high-dose chemotherapy and peripheral blood progenitor cell supportK P Papadopoulos, J Ayello, S Tugulea, et al.ESMO Open|July 10, 2024
Open-label, dose-escalation FIGHT-101 study of pemigatinib combined with targeted therapy, chemotherapy, or immunotherapy in patients with advanced malignanciesM Saleh, M Barve, V Subbiah, et al.British Journal of Cancer|June 6, 2014
Phase I ficlatuzumab monotherapy or with erlotinib for refractory advanced solid tumours and multiple myelomaA Patnaik, G J Weiss, K P Papadopoulos, et al.Bone Marrow Transplantation|July 27, 2005
Pilot study of tandem high-dose chemotherapy and autologous stem cell transplantation with a novel combination of regimens in patients with poor risk lymphomaK P Papadopoulos, W Noguera-Irizarry, L Wiebe, et al.Journal of Neuro-Oncology|January 5, 2000
A phase I study of high-dose BCNU, etoposide and escalating-dose thiotepa (BTE) with hematopoietic progenitor cell support in adults with recurrent and high-risk brain tumorsK P Papadopoulos, C Balmaceda, M Fetell, et al.Pageof 3